Diriba Getu, Kebede Abebaw, Tola Habteyes Hailu, Alemu Ayinalem, Yenew Bazezew, Moga Shewki, Addise Desalegn, Mohammed Zemedu, Getahun Muluwork, Fantahun Mengistu, Tadesse Mengistu, Dagne Biniyam, Amare Misikir, Assefa Gebeyehu, Abera Dessie, Desta Kassu
Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Tuberc Res Treat. 2021 Sep 18;2021:5239529. doi: 10.1155/2021/5239529. eCollection 2021.
In Ethiopia, tuberculosis (TB) is one of the most common causes of illness and death. However, there is limited information available on lineages associated with drug resistance among extrapulmonary tuberculosis patients in Ethiopia. In this study, researchers looked into lineages linked to drug resistance in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia.
On 151 isolates, a cross-sectional analysis was performed. Spoligotyping was used to characterize mycobacterial lineages, while a phenotypic drug susceptibility test was performed to determine the drug resistance pattern. Data were analyzed using SPSS version 23.
Among 151 complex (MTBC) genotyped isolates, four lineages (L1-L4), and were identified. The predominantly identified lineage was Euro-American (73.5%) followed by East-African-Indian (19.2%). Any drug resistance (RR) and multidrug-resistant (MDR) tuberculosis was identified among 16.2% and 7.2% of the Euro-American lineage, respectively, while it was 30.8% and 15.4% among the East-African-Indian lineages. Among all three preextensively drug-resistance (pre-XDR) cases identified, two isolates belong to T3-ETH, and the other one strain was not defined by the database. There was no statistically significant association between any type of drug resistance and either lineage or sublineages of .
A higher proportion of any type of drug resistance and MDR was detected among the East-African-Indian lineage compared to others. However, there was no statistically significant association between any type of drug resistance and either lineages or sublineages. Thus, the authors recommend a large-scale study.
在埃塞俄比亚,结核病是最常见的疾病和死亡原因之一。然而,关于埃塞俄比亚肺外结核病患者中与耐药性相关的谱系的信息有限。在本研究中,研究人员调查了埃塞俄比亚亚的斯亚贝巴肺外结核病患者中与耐药性相关的谱系。
对151株分离株进行横断面分析。使用间隔寡核苷酸分型(Spoligotyping)来鉴定分枝杆菌谱系,同时进行表型药敏试验以确定耐药模式。使用SPSS 23版软件进行数据分析。
在151株经基因分型的结核分枝杆菌复合群(MTBC)分离株中,鉴定出四个谱系(L1-L4)。主要鉴定出的谱系是欧美谱系(73.5%),其次是东非-印度谱系(19.2%)。在欧美谱系中,分别有16.2%和7.2%的菌株存在任何耐药(RR)和耐多药(MDR)结核病,而在东非-印度谱系中这一比例分别为30.8%和15.4%。在所有三例被鉴定为广泛耐药前(pre-XDR)的病例中,两株分离株属于T3-ETH,另一株未被数据库定义。任何类型的耐药性与MTBC的谱系或亚谱系之间均无统计学显著关联。
与其他谱系相比,东非-印度谱系中检测到的任何类型耐药性和MDR的比例更高。然而,任何类型的耐药性与谱系或亚谱系之间均无统计学显著关联。因此,作者建议开展大规模研究。